DrugPatentWatch Database Preview
DIETHYLPROPION HYDROCHLORIDE Drug Profile
» See Plans and Pricing
When do Diethylpropion Hydrochloride patents expire, and what generic alternatives are available?
Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Diethylpropion Hydrochloride
A generic version of DIETHYLPROPION HYDROCHLORIDE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
Summary for DIETHYLPROPION HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 10 |
| Suppliers / Packagers: | 8 |
| Bulk Api Vendors: | 29 |
| Clinical Trials: | 2 |
| Patent Applications: | 581 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DIETHYLPROPION HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | N/A |
| New River Pharmaceuticals | Phase 1/Phase 2 |
Pharmacology for DIETHYLPROPION HYDROCHLORIDE
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE
US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091680-001 | Oct 24, 2011 | AB | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Sandoz | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 085916-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Chartwell Rx | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 088268-001 | Aug 25, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
